AN OPEN-LABEL, SAFETY AND TOLERABILITY PHASE 1b TRIAL OF CAN04, A FULLY HUMANIZED ANTI-IL1RAP MONOCLONAL ANTIBODY, AND PEMBROLIZUMAB IN COMBINATION WITH AND WITHOUT CARBOPLATIN AND PEMETREXED IN SUBJECTS WITH SOLID TUMORS
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Highlands Ranch Hospital
Lone Tree Medical Center
Outpatient CTRC
University of Colorado Hospital
Study ID
Protocol Number: 20-0605
More information available at ClinicalTrials.gov: NCT04452214
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers